CRSP
CRISPR Therapeutics AG
$48.87
-2.12% ($1.06)
Volume
3.28M
52W High
$78.48
52W Low
$30.04
Market Cap
$4.60B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$1.10
Whisper EPS
-$1.10
0.4% above consensus
Last Quarter
-$1.37
Current Streak
1 Miss
Avg Surprise (4Q)
-3.20%
Next Earnings Report
Reports in 58 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Feb 17, 2026
1-Day:
+0.66%
Q4 2025
Feb 10, 2026
1-Day:
-1.04%
Q3 2025
Nov 5, 2025
1-Day:
-0.67%
5-Day:
-4.23%
Q2 2025
Aug 4, 2025
1-Day:
-6.71%
Revenue & Financial Performance
Revenue Whisper
$1.7M
TWN Proprietary Estimate
Last Quarter Revenue
$864,000
-97.5% YoY
Gross Margin
-6,770.8%
Net Margin: -10,000.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $864,000 | -97.5% | -6,770.8% | -10,000.0% | -$130.6M |
| Q3'25 | $889,000 | +47.7% | -7,177.1% | -10,000.0% | -$106.4M |
| Q2'25 | $892,000 | +72.5% | -5,062.0% | -10,000.0% | -$208.5M |
| Q1'25 | $865,000 | +71.6% | -6,548.4% | -10,000.0% | -$136.0M |
| Q4'24 | $35.0M | -82.5% | 100.0% | -184.5% | -$37.3M |
| Q3'24 | $602,000 | -99.1% | -1,852.7% | -10,000.0% | -$85.9M |
| Q2'24 | $517,000 | -99.5% | -10,000.0% | -10,000.0% | -$126.4M |
| Q1'24 | $504,000 | +8,300.0% | -10,000.0% | -10,000.0% | -$116.6M |
Company Information
Symbol
CRSP
Company
CRISPR Therapeutics AG
Market Cap
$4.60B
Next Earnings
May 11, 2026